Recursion

is a Utah-based biotechnology company that discovers and commercializes drugs for the treatment of genetic, inflammation and infectious diseases...
Read more
Recursion Co-Founder & CEO: Christopher C. Gibson

Co-Founder & CEO

Christopher C. Gibson

CEO Approval Rating

81/100

Annual Revenue
$58.8M
Employees
400
Funding
$964.6M
Acquisitions
1

Recursion Competitors

1Relay
2AbCellera
3Insitro
4X-37
5Yumanity
6BPS Bioscience
7Alector
8BERG
9Lysosomal Therapeutics
10Crown Bioscience

Trending Companies